Trial
NCT05148234
BMS-986253 in Myelodysplastic Syndromes
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
Deoxyribonucleic acid (DNA) methyltransferase inhibitors (DNMTi) Decitabine
Why stopped
Company closed the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-30